Trials / Completed
CompletedNCT02018159
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 738 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 21 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This post-marketing, multi-center prospective study will be conducted in a open-label, non-interventional setting, for women seeking fertility treatment and will describe morphokinetic de-selection parameters in human embryos.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | menotropin |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2016-02-12
- Completion
- 2016-05-12
- First posted
- 2013-12-23
- Last updated
- 2017-08-28
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02018159. Inclusion in this directory is not an endorsement.